October 09, 2026
According to Payal Rabde, who specializes in the identification, screening, and development of antibodies for therapeutic, diagnostic, and research applications, with 4+ years of experience in market research and industry analysis, extensive research...
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights,...
April 21, 2026
The antibody optimization service market was valued at USD 2.77 billion in 2024 and is projected to reach USD 6.07 billion by 2034, growing at a CAGR of 8.45%. The report covers technology segments (CRISPR, TALEN, ZFN) and applications (therapeutics,...
October 08, 2026
The global antibody drug conjugate (ADC) market is projected to grow from USD 14.76 billion in 2026 to USD 32.66 billion by 2035, registering a CAGR of 9.23%....
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
October 01, 2026
The global antibody therapy market size was estimated at USD 314.64 billion in 2025 and is predicted to increase from USD 355.80 billion in 2026 to approximately USD 951.24 billion by 2034, expanding at a CAGR of 13.08% from 2026 to 2034. Our senior ...
April 21, 2026
The next-generation bispecific antibody market is expanding due to increasing diseases as well as rising autoimmune diseases treatment approaches. North America led the market due to the presence of well-developed industries....
April 21, 2026
According to market projections, the global human combinatorial antibody libraries market, valued at USD 116.2 billion in 2024, is anticipated to reach USD 189.57 billion by 2034, growing at a CAGR of 5.04% over the next decade. The human combinatori...
September 07, 2026
According to Payal Rabde, who specializes in developing therapies that simultaneously target two different biological targets to improve disease treatment, with 4+ years of experience in market research and industry analysis, extensive research indic...
August 14, 2026
According to Payal Rabde, who specializes in engineered antibodies with improved specificity, stability, potency, and therapeutic performance for targeted disease treatment, with 4+ years of experience in market research and industry analysis, exte...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segment...
July 21, 2026
According to Payal Rabde, who specializes in the development of engineered fusion proteins, cytokine and receptor fusion proteins, and recombinant protein production and biomanufacturing, with 4+ years of experience in market research and industry an...
October 15, 2026
According to Rohan Patil, who specializes in biotechnology and pharmaceutical market research, with 5+ years of experience in market research and industry analysis. His research reveals that the antibody contract manufacturing market is projected to ...
October 15, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
April 21, 2026
According to market projections, the global complement C4 antibody market, valued at USD 21.56 billion in 2024, is anticipated to reach USD 68.48 billion by 2034, growing at a CAGR of 12.25% over the next decade. The demand for complement C4 antibodi...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
May 26, 2026
Multispecific Antibodies (By Therapy Type: Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Antibodies; By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Therapeutic Areas; By Drug Class: Monoclonal Antibodie...
February 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.5...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
October 13, 2026
According to Shivani Zoting, who specializes in Healthcare IT, Biotechnology, and Life Sciences market research, with 5+ years of experience in market research and industry analysis. Her research on the Drug Discovery Informatics Market highlights st...
April 21, 2026
The robotics in drug discovery market is growing due to rising demand for faster, accurate research and reduced human error. Automation accelerated high-throughput screening and improved efficacy in early-stage drug development....
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 21, 2026
Based on market forecasts, the Europe life science market, projected at USD 26.32 billion in 2024, is expected to reach USD 78.90 billion by 2034, growing at a CAGR of 11.61% over the forecast period. The growing public health concerns, significant s...
September 11, 2026
According to Payal Rabde, who specializes in complex research processes, advanced screening technologies, specialized expertise, and significant investment in identifying and developing promising therapeutic candidates, with 4+ years of experience in...
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for...
August 06, 2026
According to Payal Rabde, who specializes in artificial intelligence in healthcare, pharmaceutical innovation, and life sciences, with 5+ years of experience in market research and industry analysis, the AI in Drug Discovery Market is entering a phas...
April 21, 2026
Based on market forecasts, the global lead optimization services in drug discovery market, projected at USD 4.26 billion in 2024, is expected to reach USD 10.26 billion by 2034, growing at a CAGR of 9.23% over the forecast period. The lead optimizati...
September 08, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 24.32 billion in 2025 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cance...
April 21, 2026
Multiomics is highly essential in drug discovery because of its advantage in developing precision medicine. North America is dominating the multiomics in drug discovery market because of growing investment in biotechnology industry....
October 09, 2026
The Singapore computational drug discovery market is predicted to increase from USD 17.32 million in 2026 to reach around USD 125.37 million by 2035, expanding at a CAGR of 24.6% from 2026 to 2035. The report analyses the market segmentation, demand ...
April 21, 2026
Cell Dissociation Market (By Product: Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories; By Type: Tissue Dissociation, Cell Detachment; By End-use: Pharmaceutical & Biotechnology Companies, Research & Academic ...
September 08, 2026
According to Payal Rabde, who specializes in AI-driven drug design, target identification, molecular generation, virtual screening, lead optimization, drug repurposing, and pharmaceutical R&D, with 4+ years of experience in market research and in...
July 20, 2026
According to Payal Rabde, who specializes in Target identification and validation, lead optimization and candidate selection, and high-throughput screening, with 4+ years of experience in market research and industry analysis, extensive research indi...
April 21, 2026
Market insights predict the global cell signaling industry will increase from USD 6.58 billion in 2024 to USD 14.11 billion by 2034, achieving a CAGR of 7.92%. Growing research and development in healthcare is promoting the use of cell signaling....
April 21, 2026
Based on market forecasts, the global drug discovery platforms market, projected at USD 186.24 million in 2024, is expected to reach USD 635.45 million by 2034, growing at a CAGR of 13.44% over the forecast period. Drug discovery platforms use smart ...
April 10, 2026
Biotechnology and Pharmaceutical Services Outsourcing Market (By Service: Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education, Others; By End Use: Pharmaceutical Com...
April 21, 2026
Advantages of ML in drug discovery, including raised efficiency and prediction rates, are accelerating the drug discovery process as growing cases of various diseases are fueling the expansion of the market across the world. Whereas North America dom...
April 21, 2026
The drug discovery SaaS platforms market is growing as mainly used in the drug discovery process for virtual screening, data management and analysis, AI-powered drug design, facilitating collaboration, clinical trial optimization, drug repurposing, t...
April 21, 2026
According to market estimations, the molecular interaction analyzer sector size to capture US$ 337.7 million in 2025 is to soar US$ 454.1 million by 2030. The molecular interaction analyzer market is driven by increasing demand for proteomics researc...
April 21, 2026
Based on market forecasts, the life science chemical biotech instrumentation sector will expand from USD 34.23 billion in 2024 to USD 50.85 billion by 2034, experiencing a CAGR of 4.05%. The growing research and development activities and technologic...
+1 9197 992 333
+91 93077 85324
